Ultragenyx Pharmaceutical Q1 EPS $(1.84) Misses $(1.51) Estimate, Sales $136.000M Miss $158.777M Estimate

Benzinga Newsdesk www.benzinga.com Negative 95.6%

Neg 95.6% Neu 0% Pos 0%

Comments

No comments yet. Be the first!